Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years, a Pilot Study

Eight Weeks Sofosbovir/Ledipasvir in HCV Infected Children Aged 4 to 10 Years, a Pilot Study